Shopping Cart
- Remove All
- Your shopping cart is currently empty
ORM-10103 is a novel potent and selective inhibitor of the Na+/Ca2+ exchanger (NCX).ORM-10103 inhibited NCX currents with estimated IC50 values of 55 and 67 nM at -80 and 20 mV, respectively, and reduced early and delayed postdepolarization in canine hearts.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $36 | In Stock | |
5 mg | $83 | In Stock | |
10 mg | $137 | In Stock | |
25 mg | $292 | In Stock | |
50 mg | $469 | In Stock | |
100 mg | $636 | In Stock | |
200 mg | $859 | In Stock | |
1 mL x 10 mM (in DMSO) | $92 | In Stock |
Description | ORM-10103 is a novel potent and selective inhibitor of the Na+/Ca2+ exchanger (NCX).ORM-10103 inhibited NCX currents with estimated IC50 values of 55 and 67 nM at -80 and 20 mV, respectively, and reduced early and delayed postdepolarization in canine hearts. |
Targets&IC50 | NCX (20 mV):67 nM, NCX 80 mV:55nM |
Molecular Weight | 348.35 |
Formula | C20H16N2O4 |
Cas No. | 488847-28-5 |
Smiles | [O-][N+](=O)c1ccc(Oc2ccc3OC(CCc3c2)c2ccccc2)nc1 |
Relative Density. | 1.303 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (129.18 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.